title: Monitoring glaucoma progression with visual evoked potentials of the blue-sensitive pathway.
abstract: OBJECTIVE
  To determine the value of visual evoked potentials with blue-on-yellow pattern stimulation in follow-up of glaucoma.
  
  
  METHODS
  This prospective longitudinal concurrent study included a heterogeneous cohort of two groups, perimetric (n = 161) and preperimetric (n = 118), of patients with chronic open-angle glaucoma and 113 healthy control subjects. In the preperimetric glaucoma group, patients showed glaucomatous abnormalities of the optic disc, maximum intraocular pressure higher than 21 mm Hg, and unremarkable computerized visual field examination results. Patients underwent up to three VEP measurements with blue-on-yellow pattern stimulation, as well as qualitative and morphometric evaluation of color stereo optic disc photographs. Mean follow-up time between measurements was 24 months. VEP measurements were separately analyzed in preperimetric subjects, with and without progression of optic nerve damage. Progression of glaucoma was defined as increasing loss of neuroretinal rim.
  
  
  RESULTS
  A separate analysis of VEP peak times in patients in the preperimetric group, with and without progression of glaucomatous optic nerve damage, showed no significant difference at baseline but a significant prolongation (P = 0.01) in patients with progressive disease, 2 years before morphologic changes were evident. VEPs in patients with nonprogressive disease were statistically unchanged during the observation period. The perimetric group and both preperimetric groups showed significantly prolonged VEP peak times in comparison with the control group (P < 0.001).
  
  
  CONCLUSIONS
  In addition to photographic evaluation to detect glaucomatous disc atrophy, the blue-on-yellow VEP may be an objective electrophysiological tool for monitoring patients with glaucoma, because peak times are significantly associated with progression of optic nerve damage.
authors.affiliation: Department of Ophthalmology and University Eye Hospital, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. folkert.horn@augen.imed.uni-erlangen.de
authors.forename: Folkert K
authors.initials: FK
authors.lastname: Horn
authors.forename: Jost B
authors.initials: JB
authors.lastname: Jonas
authors.forename: Wido M
authors.initials: WM
authors.lastname: Budde
authors.forename: Anselm M
authors.initials: AM
authors.lastname: Jünemann
authors.forename: Christian Y
authors.initials: CY
authors.lastname: Mardin
authors.forename: Matthias
authors.initials: M
authors.lastname: Korth
mesh_terms: D002908:Chronic Disease; D018450:Disease Progression; D005074:Evoked Potentials, Visual; D005260:Female; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D009898:Optic Disk / Q000503:physiopathology; D009901:Optic Nerve Diseases / Q000175:diagnosis / Q000503:physiopathology; D011237:Predictive Value of Tests; D011446:Prospective Studies; D058609:Visual Field Tests